To evaluate the efficacy of Leucronil tablets in the patients suffering from white discharge per vagina
Not Applicable
Completed
- Conditions
- Health Condition 1: N80-N98- Noninflammatory disorders of female genital tractHealth Condition 2: null- patients suffering from Leucorrhea
- Registration Number
- CTRI/2015/02/005515
- Lead Sponsor
- yurvedic Research Foundation Pvt ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married females of Age group 20 to 40 years having leucorrhoea due to non-infective cervical lesions e.g. cervical erosion, chronic cervicitis, mucous polyps, increased pelvic congestion e.g. uterine prolapsed, acquired retroverted uterus, chronic pelvic inflammation
Controlled diabetes
Exclusion Criteria
i.Pregnant or lactating women
ii.Patients on Oral Contraceptive Pills
iii.Patients with IUCD
iv.Patients with physiological leucorrhoea (e.g. during ovulation, pre-menstrual, pregnancy)
v.Patients with abnormal (excessive) vaginal discharge due to neoplasmic changes
vi.Positive history of venereal diseases
vii.Patients suffering from uncontrolled diabetes
viii.Patients with Anemia (Hb% below 7)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcomes of the study will be measured in terms of clinical signs - per vaginal examination and symptoms <br/ ><br>Pap smear test <br/ ><br>microbiological improvement. <br/ ><br> <br/ ><br>Timepoint: Every 15 days for a period of one month <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate the safety and tolerability of the formulation in patientsa suffering from LeucorrheaTimepoint: Every 15 days